Only CD11b+Ly6C−Ly6G+ PMN-MDSCs among tumor-infiltrating immune cells were increased in Stk11-KO tumors with an adjusted P value = 0.082 (Fig. 6H). The gene discussed is STK11; the disease is neoplasm.